CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-08 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) | −6,000 | 0 | ||
| 2025-04-08 | Lukatch Heath Director | Option exercise · Stock Option (right to buy) | −1,000 | 14,000 | ||
| 2025-04-07 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise | +4,777 | $20.93 | $100K | 131,950 |
| 2025-04-07 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) | −4,777 | 121,115 | ||
| 2025-04-04 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise | +15,781 | $5.35 | $84K | 514,023 |
| 2025-04-04 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise | +4,752 | $20.93 | $99K | 518,775 |
| 2025-04-04 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) | −15,781 | 186,936 | ||
| 2025-04-04 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) | −4,752 | 298,360 | ||
| 2025-03-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Grant or award | +57,938 | 508,239 | ||
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 46,620 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −2,621 | $70.39 | $184K | 43,999 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −2,267 | $71.07 | $161K | 41,732 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −112 | $72.37 | $8K | 41,620 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 144,497 | ||
| 2025-03-03 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −3,809 | $72.10 | $275K | 127,173 |
| 2025-03-03 | Cowan Elvia SVP, FINANCE | Shares withheld for taxes | −325 | $72.10 | $23K | 24,106 |
| 2025-03-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes | −616 | $72.10 | $44K | 41,620 |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +2,638 | $2.42 | $6K | 157,569 |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +5,362 | $5.35 | $29K | 162,931 |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −5,915 | $73.07 | $432K | 157,016 |
Page 11 of 16 · 319 trades